Back

Incremental benefits of echocardiographic indices over clinical parameters for screening cardiac amyloidosis in patients with left ventricular hypertrophy

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Echocardiography in Patients with Left Ventricular Hypertrophy: What’s New? Tissue Doppler, Speckle Tracking and Strain Imaging ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Makoto Saito

Kitaishikai Hospital, Ozu (Japan)

6 More presentations in this session

Presentation thumbnail
Relationship between pulmonary edema development and left atrium mechanical functions in patients with left ventricular hypertrophy
Doctor B. Aggul (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Differentiation of hypertensive heart disease and hypertrophic cardiomyopathy with myocardial stiffness measurements: a shear wave imaging study using ultra-high frame rate echocardiography
Doctor M. Cvijic (Ljubljana, SI)
Abstract Slides
Presentation thumbnail
The prognostic value of novel myocardial deformation parameters for sudden events in hypertrophic cardiomyopathy.
Doctor T. Zegkos (Thessaloniki, GR)
Abstract Slides
Presentation thumbnail
Prognostic value of reduced heart rate reserve during exercise stress-echocardiography in hypertrophic cardiomyopathy
Doctor Q. Ciampi (Benevento, IT)
Abstract Slides
Presentation thumbnail
Value of a comprehensive exercise echocardiography assessment for patients with hypertrophic cardiomyopathy
Doctor J. Peteiro Vazquez (A Coruna, ES)
Abstract Slides

Access the full session

Session thumbnail
Echocardiography in Patients with Left Ventricular Hypertrophy: What’s New?

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources